CHIKUNGUNYA VIRUS INFECTION
Clinical trials for CHIKUNGUNYA VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear
Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists track 10-Year protection of Single-Shot virus vaccine
⭐️ VACCINE ⭐️ OngoingThis study is checking how long a single dose of an experimental chikungunya vaccine keeps protecting people and if it remains safe over many years. It follows about 375 adults who got the vaccine in a previous trial, checking their immunity and health annually for up to 10 years…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: PHASE3 • Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 04, 2026 00:51 UTC
-
Massive 5,000-Person study tracks safety of new chikungunya shot
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis study is carefully watching for side effects in 5,000 people in Brazil who have already received a new vaccine for chikungunya virus. The main goal is to understand how common certain health concerns are after vaccination, including heart issues and joint pain. Researchers w…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:32 UTC
-
Brazil tests new chikungunya vaccine in Real-World rollout
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis study aims to measure how well the VLA1553 vaccine prevents chikungunya virus disease in real-world conditions in Brazil. Researchers will compare about 1,200 people who develop chikungunya-like symptoms, checking if vaccinated individuals are less likely to test positive fo…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 25, 2026 14:07 UTC
-
Groundwork laid for first Kids' shield against painful mosquito virus
⭐️ VACCINE ⭐️ TerminatedThis study aimed to test a vaccine designed to protect children from the chikungunya virus, a painful mosquito-borne illness. It planned to enroll at least 3,000 healthy children aged 1 to 11 years to receive either the experimental vaccine or a comparator vaccine. The main goal …
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Phase: PHASE3 • Sponsor: Valneva Austria GmbH • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 23, 2026 15:19 UTC
-
Brazilian communities tested for chikungunya immunity before vaccine launch
Knowledge-focused OngoingThis study aims to understand how many people in selected Brazilian communities already have immunity to the chikungunya virus before a new vaccine is introduced. Researchers will test over 5,300 residents, aged 2 and up, from randomly selected households. The goal is to gather i…
Matched conditions: CHIKUNGUNYA VIRUS INFECTION
Sponsor: Valneva Austria GmbH • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC